Search for: "BioScrip, Inc."
Results 1 - 5
of 5
Sorted by Relevance
|
Sort by Date
28 Aug 2019, 7:52 am
The complaint alleged that share prices for BioScrip, Inc., a home infusion and pharmacy provider, declined after it failed to disclose possible violations of the Anti-Kickback Statute (AKS) and False Claims Act (FCA) and that one of its most profitable business segments was collapsing. [read post]
22 Mar 2022, 7:18 am
In JLM Couture, Inc. v. [read post]
9 Mar 2017, 1:31 pm
Discussion: In 2014, two specialty pharmacies, Bioscrip and Accredo agreed to pay $15 million and $60 million[6] respectively to resolve allegations that the specialty pharmacies accepted kickbacks in the form of rebates and patient referrals in exchange for promoting certain drugs over competitor products.[7] These allegations were brought by a whistleblower under the FCA. [read post]
18 Jul 2011, 4:00 am
Bioscrip Pharmacy Services, Inc., No. 10-2203 (10th Cir. [read post]
29 Feb 2016, 4:43 pm
See, e.g., In re BioScrip, Inc. [read post]
